Ticker Scorecard - ATNM Basics Company: Actinium Pharmaceuticals, Inc IPO Date: January 1, 2003 Sector: Healthcare Industry: Biotech Market Cap: $38.06M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 3.47% Avg Daily Range (30 D): $0.05 | 4.00% Avg Daily Range (90 D): $0.06 | 3.60% Institutional Daily Volume Avg Daily Volume: .16M Avg Daily Volume (30 D): .29M Avg Daily Volume (90 D): .26M Trade Size Avg Trade Size (Sh.): 71 Avg Trade Size (Sh.) (30 D): 178 Avg Trade Size (Sh.) (90 D): 153 Institutional Trades Total Inst.Trades: 45 Avg Inst. Trade: $1.85M Avg Inst. Trade (30 D): $.95M Avg Inst. Trade (90 D): $.95M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.07M Avg Closing Trade (30 D): $3.9M Avg Closing Trade (90 D): $3.9M Avg Closing Volume: 288.69K     News Dec 16, 2024 @ 3:53 PM Targeted Alpha Therapy Market, Drugs Approval, Pro... Source: Researchandmarkets.Com Oct 21, 2024 @ 5:00 PM Allogeneic Hematopoietic Stem Cell Transplant Mark... Source: Delveinsight Sep 9, 2024 @ 8:56 AM Lutetium-177 Industry Research Report 2024: Carrie... Source: Researchandmarkets.Com Jun 20, 2024 @ 1:40 PM Is Actinium Pharmaceuticals (ATNM) Outperforming O... Source: Zacks Equity Research Jun 4, 2024 @ 1:40 PM Is Affimed (AFMD) Outperforming Other Medical Stoc... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.39 $-.37 $-.38 Diluted EPS $-1.39 $-.37 $-.38 Revenue $ .08M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -40.92M $ -11.57M $ -11.35M Operating Income / Loss $ -44.96M $ -12.6M $ -12.42M Cost of Revenue $ $ $ Net Cash Flow $ -4.31M $ -7.37M $ 1.98M PE Ratio     Splits Aug 11, 2020:   30:1